The use of a common cholesterol medication to support HER2-targeted cancer therapy is validated by PET imaging.

Published Date: 18 Oct 2023

A novel therapeutic strategy that lowers the number of cancer treatments needed to prevent tumor growth by combining lovastatin, a cholesterol-lowering medication, with human epidermal growth receptor factor 2 (HER2)-targeted therapies.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Enhanced access for patients with prostate cancer is provided by the new SPECT/CT technique, which demonstrates remarkable biomarker identification.

2.

Reducing social media to an hour a day boosts young people's self-image.

3.

Utilizing cerium/lanthanum-134 to improve cancer detection and treatment.

4.

Clinical trial: Patients with locally advanced, muscle-invasive bladder cancer do not benefit from extended lymph node removal.

5.

Can Concurrent Boost Safely Shorten Breast Cancer Radiation?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot